Could cause temporary or reversible harm; serious harm is unlikely.
Presence of Foreign Tablets/Capsules: Customer complaint that one 20 mg Atorvastatin Calcium Tablet was present in a bottle labeled as and containing eight-nine Atorvastatin Calcium Tablets, USP 10 mg.
| Distributed by / for | Biocon Pharma Inc., Iselin, NJ 08830-3009 USA; |
| NDC | 70377-027-11 |
| Full product label | Atorvastatin Calcium Tablets, USP, 10 mg*, 90-count bottle, Rx Only, Manufactured for: Biocon Pharma Inc., Iselin, NJ 08830-3009 USA; Manufactured By: Graviti Pharmaceuticals Pvt. Ltd., Telangana -502307, INDIA; NDC 70377-027-11. |
| Recalling firm | Graviti Pharmaceuticals Private Limited |
| Distribution | Nationwide in the USA. |
| Quantity | 29,056 bottles |
| Recall initiated | 2020-01-28 |
| Report date | 2020-02-12 |
| Recall completed | 2022-11-29 |
| Recall number | D-0832-2020 |
| Classification | Class II |
| FDA status | Terminated |
| Origin on file | Medak N/A India |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗